Lee Ainslie Charles River Laboratories International, Inc. Transaction History

Maverick Capital LTD

  • $4.82 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$372.64 - $458.3 $572,375 - $703,948
-1,536 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$294.17 - $371.65 $989,293 - $1.25 Million
-3,363 Reduced 68.65%
1,536 $568,000
Q1 2021

May 17, 2021
BUY
$249.67 - $299.48 $1.22 Million - $1.47 Million
4,899 New
4,899 $1.42 Million
Q4 2020

Feb 16, 2021
SELL
$222.0 - $252.62 $257,964 - $293,544
-1,162 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$175.56 - $226.45 $204,000 - $263,134
1,162 New
1,162 $263,000

Others Institutions Holding CRL

# of Institutions
691
Shares Held
51.6M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email